Antibiotics and coronary heart disease

Comment

F Javier Nieto. JAMA. 2004.

. 2004 Jan 21;291(3):302-3; author reply 303.

doi: 10.1001/jama.291.3.302-b.

No abstract available

Comment on

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD; Investigators in the WIZARD Study. O'Connor CM, et al. JAMA. 2003 Sep 17;290(11):1459-66. doi: 10.1001/jama.290.11.1459. JAMA. 2003. PMID: 13129985 Clinical Trial.
Antibiotic therapy for coronary artery disease: can a WIZARD change it all?
Pislaru SV, Van de Werf F. Pislaru SV, et al. JAMA. 2003 Sep 17;290(11):1515-6. doi: 10.1001/jama.290.11.1515. JAMA. 2003. PMID: 13129994 No abstract available.